BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35730473)

  • 1. Can we predict the progression of premalignant pancreatic cystic tumors to ductal adenocarcinoma?
    Chidambaram S; Kawka M; Gall TM; Cunningham D; Jiao LR
    Future Oncol; 2022 Jul; 18(23):2605-2612. PubMed ID: 35730473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cystic pancreatic tumors: diagnostics and new biomarkers].
    Berger AW; Seufferlein T; Kleger A
    Chirurg; 2017 Nov; 88(11):905-912. PubMed ID: 28831506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
    Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma].
    Ott C; Heinmöller E; Gaumann A; Schölmerich J; Klebl F
    Med Klin (Munich); 2007 Feb; 102(2):127-35. PubMed ID: 17323019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications.
    Singh M; Maitra A
    Pancreatology; 2007; 7(1):9-19. PubMed ID: 17449961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic characteristics of pancreatic intraepithelial neoplasia associated with different pancreatic lesions.
    Recavarren C; Labow DM; Liang J; Zhang L; Wong M; Zhu H; Wang J; Francis F; Xu R
    Hum Pathol; 2011 Jan; 42(1):18-24. PubMed ID: 21056895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.
    Zhu J; Wu J; Pei X; Tan Z; Shi J; Lubman DM
    PLoS One; 2017; 12(4):e0175039. PubMed ID: 28369074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer?
    Haugk B
    Histopathology; 2010 Oct; 57(4):503-14. PubMed ID: 20875068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis.
    Muraki T; Jang KT; Reid MD; Pehlivanoglu B; Memis B; Basturk O; Mittal P; Kooby D; Maithel SK; Sarmiento JM; Christians K; Tsai S; Evans D; Adsay V
    Mod Pathol; 2022 Jan; 35(1):96-105. PubMed ID: 34518632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current understanding of precursors to pancreatic cancer.
    Takaori K
    J Hepatobiliary Pancreat Surg; 2007; 14(3):217-23. PubMed ID: 17520195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precursor Lesions of Pancreatic Cancer.
    Kim JY; Hong SM
    Oncol Res Treat; 2018; 41(10):603-610. PubMed ID: 30269131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
    Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M
    Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA from pancreatic duct aspirate differentiates cystic lesions of the pancreas.
    Henry JC; Bassi C; Giovinazzo F; Bloomston M
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S661-6. PubMed ID: 23884752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic intraepithelial neoplasia in patients with intraductal papillary mucinous neoplasms: the interest of endoscopic ultrasonography.
    Maire F; Couvelard A; Palazzo L; Aubert A; Vullierme MP; Rebours V; Hammel P; Sauvanet A; Levy P; Ruszniewski P
    Pancreas; 2013 Nov; 42(8):1262-6. PubMed ID: 24152960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic intraepithelial neoplasia.
    Takaori K; Hruban RH; Maitra A; Tanigawa N
    Pancreas; 2004 Apr; 28(3):257-62. PubMed ID: 15084967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precancerous lesions of the pancreas.
    Zamboni G; Hirabayashi K; Castelli P; Lennon AM
    Best Pract Res Clin Gastroenterol; 2013 Apr; 27(2):299-322. PubMed ID: 23809247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
    Biankin AV; Kench JG; Dijkman FP; Biankin SA; Henshall SM
    Pathology; 2003 Feb; 35(1):14-24. PubMed ID: 12701679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current topics on precursors to pancreatic cancer.
    Takaori K; Hruban RH; Maitra A; Tanigawa N
    Adv Med Sci; 2006; 51():23-30. PubMed ID: 17357272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic adenocarcinoma: update on the surgical pathology of carcinomas of ductal origin and PanINs.
    Hruban RH; Fukushima N
    Mod Pathol; 2007 Feb; 20 Suppl 1():S61-70. PubMed ID: 17486053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.